Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely ...
May 24, 2023
0
28
A Rutgers researcher leading a trial found that the novel combination antibiotic sulbactam-durlobactam combats dangerous pneumonia at least as well as the best currently approved treatment.
May 16, 2023
0
50
Drugs approved in the US require "substantial evidence" that they are effective. But an investigation by The BMJ into the recent approval of the antibiotic Recarbrio from Merck suggests that these standards are being bypassed.
May 15, 2023
0
81
Researchers at the UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center have found that mailing human papillomavirus (HPV) self-collection tests and offering assistance to book in-clinic ...
May 11, 2023
0
63
A "peanut patch" worn on the skin may help protect toddlers who have potentially life-threatening peanut allergies, a new clinical trial shows.
May 11, 2023
0
44
For the first time, researchers described the structure of a special type of amyloid beta plaque protein associated with Alzheimer's disease (AD) progression. In a report published May 10 in the journal Neuron, scientists ...
May 10, 2023
0
92
COVID vaccines offered varying degrees of protection in the six months after patients receive them, with levels climbing and plunging in two cases and climbing and climbing in another, according to new UC San Francisco research ...
May 9, 2023
0
51
Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly 16-fold from $11.25 in 2009 to $190.49 in 2011. Out-of-pocket ...
May 8, 2023
0
21
US pharmaceutical giant Eli Lilly on Wednesday announced its experimental Alzheimer's drug significantly slowed cognitive and functional decline, results hailed as "remarkable" by experts despite some patients experiencing ...
May 3, 2023
0
129
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have created a promising injectable cell therapy to treat osteoarthritis that both reduces inflammation and also regenerates articular cartilage.
Apr 22, 2023
1
705
